{"status":"OK","data":{"advertisement":{"id":236735,"title":"Zapytanie ofertowe 15 11 2023 B (RFQ 15 11 2023 B)","partial_offer_allowed":true,"publication_date":"2023-11-15","submission_deadline":"2023-11-22 23:59:59","planned_sign_date":"2023-12-01","supplementary_orders":"Zgodnie z tre\u015bci\u0105 zapytania ofertowego.","terms_of_contract_change":"Zgodnie z tre\u015bci\u0105 zapytania ofertowego.","created_at":"2023-11-15 17:15:48","modified_at":"2023-11-23 00:00:03","contact_persons":[{"id":58,"forename":"Anna","surname":"Dziedzicka","phone_number":"+48 538 512 756","email":"vendors.clinical@ryvu.com","created_by":null,"created_at":"2025-07-31 13:43:16","modified_at":"2025-07-31 13:43:16","modified_by":null}],"orders":[{"id":384874,"estimated_value":null,"order_items":[{"id":434204,"description":"hERG IC50 automated patch clamp assay:\n\u00ad\tnon-GLP study to investigate the effect of test compounds on hERG channel stably expressed in HEK-293 cells;\n\u00ad\tautomated patch clamp system;\n\u00ad\tIC50 determination;\n\u00ad\tat least 5 concentrations to be tested in duplicate (N=2);\n\u00ad\tmaterial result in a form of a study protocol and/or a report.\n\nMinimum number of samples to test/number of experiments to perform during the term of the contract is 10. \nMaximum number of samples to test/number of experiments to perform during the term of the contract is 30. ","warranty_period":null,"cpv_items":[{"id":8514,"code":"73110000-6","name":"Us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"id":486844,"type":{"id":1,"name":"adres"},"group_uuid":"ecc9e529-4bc4-41d0-a028-ade0249c7dcd"}],"participation_conditions":[{"id":1186539,"description":"Wymagania zamieszczono w za\u0142\u0105czonym Zapytaniu Ofertowym.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"group_uuid":"47ab706c-6dae-4d57-9d89-4e4918519037"},{"id":1186540,"description":"Uzupe\u0142niony Za\u0142\u0105cznik 1 (Appendix 1).","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"group_uuid":"62a1ea73-1a06-45e4-af63-11d5d9005482"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"group_uuid":"6e3afafa-21d8-47c1-954f-d532efd97e69"}],"evaluation_criteria":[{"id":661079,"price_criterion":true,"description":"Cena 100% (net price)","created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"group_uuid":"52718052-0236-41f9-9d31-7ec2c6e9979e"}],"is_variant":false,"title":"hERG IC50 automated patch clamp assay","order_node":{"id":292191},"created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null},{"id":384875,"estimated_value":null,"order_items":[{"id":434205,"description":"Assay on hiPSC-CMs with screening protocol:\n- each compound tested at 2 concentrations (N\u22653)\n- vehicle control and positive control included\n- serum-free media loaded with a voltage sensitive dye\n- voltage protocol according to CiPA\n- electrical activity assessment at baseline and 30 min after vehicle or compound addition\n- assessed parameters: APD30, 50 and 90, rate of rise and fall, triangularisation,  cycle length and diastolic interval\n\nhiPSC-CMs**\n- human iPSC-CMs purchase costs\n\nReport\n- methodology, raw data, graphical and descriptive data presentation\n- data presented as percentage change of baseline, normalized to the percentage change for vehicle control\n- quantification and classification of arrhythmic events\n\nOptional: compound ranking\n- scoring system for pro-arrhythic risk and altered excitability\n\n* Assume shipment of 5 batches in total, with up to 6 compounds per single batch\n** It should be stated, how many compounds might be tested with 1 vial of the cells; possible shipment of a more compounds per batch.\n\nMinimum number of batches to be sent during the term of the contract is 1. \nMaximum number of batches to be sent during the term of the contract is 5. ","warranty_period":null,"cpv_items":[{"id":8514,"code":"73110000-6","name":"Us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"id":486845,"type":{"id":1,"name":"adres"},"group_uuid":"ea9fb5a6-4d52-4dc0-9aef-35844cea6a7d"}],"participation_conditions":[{"id":1186541,"description":"Wymagania zamieszczono w za\u0142\u0105czonym Zapytaniu Ofertowym.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"group_uuid":"b0fcdd4c-6e86-4791-a1e3-f37a8c747895"},{"id":1186542,"description":"Uzupe\u0142niony Za\u0142\u0105cznik 1 (Appendix 1).","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"group_uuid":"0d81b646-5b19-4551-94d2-dcd71f42bf35"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"group_uuid":"357b875a-df5a-4946-a7d1-4c23e0641197"}],"evaluation_criteria":[{"id":661080,"price_criterion":true,"description":"Cena 100% (net price)","created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"group_uuid":"f15ca054-41c6-428f-9c20-8ba2a0721ad5"}],"is_variant":false,"title":"Assay on hiPSC-CMs with screening protocol","order_node":{"id":292192},"created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null},{"id":384876,"estimated_value":null,"order_items":[{"id":434206,"description":"Assay on hiPSC-CMs with deep protocol \n- human iPSC-CM purchase costs must be included*\n- each compound to be tested at 4-5 concentrations (N\u22656)\n- vehicle control and technical control (internal reference) must be included\n- assay must be run in serum-free media, loaded with voltage sensitive dye, with voltage protocol (CiPA), to study electrical activity on hiPSC-CM\n- voltage assessment at baseline, and 30 min after vehicle, compound or internal reference treatment\n- parameters to be assessed: APD 30, 50 and 90, cycle length, rate of rise and fall, triangularisation and diastolic interval must be included.\n\nReport\n- would include methodology, raw data, graphical and descriptive data presentation\n- for each parameter, data would be presented as percentage change of baseline, and compared with percentage changes for vehicle control\n- in case of arrhythmic events, quantification and classification would be also included\n- timelines for report preparation\n\n* Assume shipment of 5 batches in total, with up to 2 compounds per single batch\n* It should be stated, how many compounds might be tested with 1 vial of the cells; possible shipment of a more compounds per batch.\n\nMinimum number of batches to be sent during the term of the contract is 1. \nMaximum number of batches to be sent during the term of the contract is 5. ","warranty_period":null,"cpv_items":[{"id":8514,"code":"73110000-6","name":"Us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"id":486846,"type":{"id":1,"name":"adres"},"group_uuid":"a0553aa0-a644-4234-81cc-69304fb5e432"}],"participation_conditions":[{"id":1186543,"description":"Wymagania zamieszczono w za\u0142\u0105czonym Zapytaniu Ofertowym.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"group_uuid":"bcb0323e-0a17-4265-aed9-da008f1f7bee"},{"id":1186544,"description":"Uzupe\u0142niony Za\u0142\u0105cznik 1 (Appendix 1).","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"group_uuid":"14e296d3-7ed8-4156-b9c2-812ecc2ff887"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"group_uuid":"f17f99b1-8869-441e-ae5c-e0c0d3af76a3"}],"evaluation_criteria":[{"id":661081,"price_criterion":true,"description":"Cena 100% (net price)","created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null,"group_uuid":"2cfaa4a1-e836-4dda-ba1f-312a0529e1c4"}],"is_variant":false,"title":"Assay on hiPSC-CMs with deep protocol","order_node":{"id":292193},"created_by":null,"created_at":"2023-11-15 17:15:48","modified_at":"2023-11-15 17:15:48","modified_by":null}],"created_by":{"id":112,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"RYVU THERAPEUTICS S.A.","identification_number_type":"nip","identification_number":"6792942955","address":{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":625013,"street":"Leona Sternbacha","number_description":"2","postcode":"30-394"},"created_by":{"id":112,"contact_persons":[]},"created_at":"2023-11-15 17:15:47","modified_at":"2023-11-15 17:15:47","modified_by":{"id":112,"contact_persons":[]},"id":237283},"advertisement":{"id":180245,"number":"2023-112-180245","publication_date":"2023-11-15","created_by":{"id":112,"contact_persons":[]},"created_at":"2023-11-15 17:15:47","modified_at":"2023-11-23 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[236735],"enrollment":{"id":39917,"name":"Rozw\u00f3j celowanej terapii przeciwnowotworowej opartej o zahamowanie helikazy WRN (CanSL)","number":"002/23","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":null},"full_number":"FENG.01.01-IP.02-002/23","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2023-07-17 12:04:06","modified_at":"2023-07-17 12:04:06","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":236735,"publication_date":"2023-11-15"},"id":1193158,"name":"RFQ 15 11 2023 B (Zapytanie ofertowe 15 11 2023 B)","file":{"id":1329565,"name":"RFQ 15 11 2023 B.pdf","created_at":"2023-11-15 17:13:35","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1329565"},"group_uuid":"b2f183da-6541-40b7-b686-5efc5fa6d1f0"},{"origin":{"id":236735,"publication_date":"2023-11-15"},"id":1193159,"name":"Offer form/Appendix 1 (Formularz ofertowy)","file":{"id":1329566,"name":"Offer form to RFQ 15 11 2023 B (Appendix 1).docx","created_at":"2023-11-15 17:14:36","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1329566"},"group_uuid":"034f42c9-6f10-4c54-93b5-8c3fd848ba8c"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}